Cheng Andrew
SEC insider (Form 3/4/5 filer). CIK 0001778307. Director at Damora Therapeutics, Inc. (DMRA) and 3 other issuers. 57 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in WALTHAM, MA.
Companies Cheng Andrew has filed insider reports for
- Damora Therapeutics, Inc. (DMRA): Director
- TCGX Acquisition Corp. (TCGX): Director
- Vera Therapeutics, Inc. (VERA): Director
- Akero Therapeutics, Inc. (AKRO): Director, Officer, President and CEO
Cheng Andrew
CIK: 0001778307
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (57 total)
- Aug 12, 2026DMRA
Damora Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30.4K shares- - May 21, 2026VERA
Vera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect159.8K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect277.1K shares- - Nov 20, 2025AKRO
Akero Therapeutics, Inc.
GiftDirect74.5K shares- - Nov 12, 2025AKRO
Akero Therapeutics, Inc.
GiftDirect14.7K shares- - Oct 10, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect30K shares at avg. $53.98$1.6M - Oct 10, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect30K shares at avg. $19.87$596K - Oct 8, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect52.2K shares at avg. $0.61$32K - Sep 11, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect1.8K shares at avg. $43.02$77K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 |  DMRA Damora Therapeutics, Inc. | Award Stock Option (right to buy) | 30,350 | - | - | Direct |
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award Stock Option (right to buy) | 17,084 | - | - | Direct |
| Dec 9, 2025 |  AKRO Akero Therapeutics, Inc. | Disposition | 159,762 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 277,075 | - | - | Direct |
| Nov 20, 2025 | AKRO Akero Therapeutics, Inc. | Gift | 74,538 | - | - | Direct |
| Nov 12, 2025 | AKRO Akero Therapeutics, Inc. | Gift | 14,739 | - | - | Direct |
| Oct 10, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 30,000 | $53.98 | $1,619,340 | Direct |
| Oct 10, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 30,000 | $19.87 | $596,100 | Direct |
| Oct 8, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 52,212 | $0.61 | $32,110 | Direct |
| Sep 11, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 1,796 | $43.02 | $77,264 | Direct |
1-10 of 57 transactions